B Hampel
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 12
- Antibiotics Pharmacokinetics and Efficacy 11
-
- Cystic Fibrosis Research Advances 9
- Inhalation and Respiratory Drug Delivery 3
- Co-authors
- Peter Reimnitz (12 shared papers)H. Schmidt (1 shared paper)R Hullmann (1 shared paper)P. Koeppe (6 shared papers)Jeff Alder (8 shared papers)H. Lode (5 shared papers)Tobias Welte (4 shared papers)Anthony De Soyza (4 shared papers)
- Journals
- European Respiratory Journal (4 papers)The Pediatric Infectious Disease Journal (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Drugs (2 papers)International Journal of Antimicrobial Agents (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
B Hampel
26 papers receiving 824 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 161
- Applied Microbiology and Biotechnology 59
- Pharmacology 333
- Clinical Biochemistry 72
- Epidemiology 359
Countries citing papers authored by B Hampel
This map shows the geographic impact of B Hampel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Hampel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Hampel more than expected).
Fields of papers citing papers by B Hampel
This network shows the impact of papers produced by B Hampel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Hampel. The network helps show where B Hampel may publish in the future.
Co-authors
The 25 scholars most cited alongside B Hampel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 160 | |
| 2 | 1997 | 126 | |
| 3 | 2000 | 71 | |
| 4 | 1997 | 54 | |
| 5 | 1985 | 50 | |
| 6 | 2011 | 48 | |
| 7 | 2001 | 44 | |
| 8 | 1997 | 43 | |
| 9 | 1996 | 43 | |
| 10 | 2010 | 39 | |
| 11 | 2009 | 36 | |
| 12 | 2009 | 34 | |
| 13 | 1988 | 29 | |
| 14 | 1985 | 23 | |
| 15 | 2012 | 17 | |
| 16 | 1996 | 16 | |
| 17 | The pharmacokinetics of sultamicillin. | 1989 | 11 |
| 18 | 1982 | 7 | |
| 19 | 1990 | 7 | |
| 20 | 2011 | 5 |
About B Hampel
B Hampel is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Medicine and Emergency Medical Services, having authored 26 papers that have together received 876 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Cystic Fibrosis Research Advances (9 papers), Pediatric health and respiratory diseases (6 papers), Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antibiotic Use and Resistance (5 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Molecular Medicine (161 citations), Applied Microbiology and Biotechnology (59 citations), Pharmacology (333 citations), Clinical Biochemistry (72 citations) and Epidemiology (359 citations). B Hampel has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Peter Reimnitz, H. Schmidt, R Hullmann, P. Koeppe, Jeff Alder, H. Lode, Tobias Welte, Anthony De Soyza, Bernd Sommerauer and Eva Polverino. Their work appears in journals such as European Respiratory Journal, The Pediatric Infectious Disease Journal, Antimicrobial Agents and Chemotherapy, Drugs and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.